These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9920028)

  • 1. Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies.
    Sobao Y; Tsuchiya N; Takiguchi M; Tokunaga K
    Arthritis Rheum; 1999 Jan; 42(1):175-81. PubMed ID: 9920028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
    el-Zaatari FA; Sams KC; Taurog JD
    J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703.
    Villadangos JA; Galocha B; García F; Albar JP; López de Castro JA
    Eur J Immunol; 1995 Aug; 25(8):2370-7. PubMed ID: 7664799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several HLA alleles share overlapping peptide specificities.
    Sidney J; del Guercio MF; Southwood S; Engelhard VH; Appella E; Rammensee HG; Falk K; Rötzschke O; Takiguchi M; Kubo RT
    J Immunol; 1995 Jan; 154(1):247-59. PubMed ID: 7527812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B*2707 differs in peptide specificity from B*2705 and B*2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis.
    Gómez P; Montserrat V; Marcilla M; Paradela A; de Castro JA
    Eur J Immunol; 2006 Jul; 36(7):1867-81. PubMed ID: 16783853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B27: a registry of constitutive peptide ligands.
    Lopez de Castro JA; Alvarez I; Marcilla M; Paradela A; Ramos M; Sesma L; Vázquez M
    Tissue Antigens; 2004 May; 63(5):424-45. PubMed ID: 15104674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis.
    Lamas JR; Paradela A; Roncal F; López de Castro JA
    Arthritis Rheum; 1999 Sep; 42(9):1975-85. PubMed ID: 10513815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended repertoire of permissible peptide ligands for HLA-B*2702.
    Raghavan M; Lebrón JA; Johnson JL; Bjorkman PJ
    Protein Sci; 1996 Oct; 5(10):2080-8. PubMed ID: 8897608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide binding to empty HLA-B27 molecules of viable human cells.
    Benjamin RJ; Madrigal JA; Parham P
    Nature; 1991 May; 351(6321):74-7. PubMed ID: 2027387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
    Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
    J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the importance of each residue in a HLA-B27-binding peptide using monoclonal antibodies.
    Fukazawa T; Wang J; Huang F; Wen J; Tyan D; Williams KM; Raybourne RB; Yu DT
    J Immunol; 1994 Feb; 152(3):1190-6. PubMed ID: 8301123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition.
    Villadangos JA; Galocha B; López D; Calvo V; López de Castro JA
    J Immunol; 1992 Jul; 149(2):505-10. PubMed ID: 1378067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino acid at position 97 is involved in folding and surface expression of HLA-B27.
    Blanco-Gelaz MA; Suárez-Alvarez B; González S; López-Vázquez A; Martínez-Borra J; López-Larrea C
    Int Immunol; 2006 Jan; 18(1):211-20. PubMed ID: 16361312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody that recognizes HLA-B27 in the context of peptides.
    Wang J; Yu DT; Fukazawa T; Kellner H; Wen J; Cheng XK; Roth G; Williams KM; Raybourne RB
    J Immunol; 1994 Feb; 152(3):1197-205. PubMed ID: 8301124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.
    Boisgérault F; Tieng V; Stolzenberg MC; Dulphy N; Khalil I; Tamouza R; Charron D; Toubert A
    J Clin Invest; 1996 Dec; 98(12):2764-70. PubMed ID: 8981922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis.
    García-Peydró M; Martí M; López de Castro JA
    J Immunol; 1999 Aug; 163(4):2299-305. PubMed ID: 10438975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subtypes of the HLA-B27 molecule and association with spondylarthropathies].
    Toubert A; Tieng V; Boisgérault F; Dulphy N; Tamouza R; Charron D
    Ann Med Interne (Paris); 1998 Apr; 149(3):145-8. PubMed ID: 11490536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring myelin basic protein for HLA class I-binding sequences.
    Tanigaki N; Fruci D; Groome N; Butler RH; Londei M; Tosi R
    Eur J Immunol; 1994 Sep; 24(9):2196-202. PubMed ID: 7522167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
    Barber LD; Percival L; Arnett KL; Gumperz JE; Chen L; Parham P
    J Immunol; 1997 Feb; 158(4):1660-9. PubMed ID: 9029102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.